• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025

    5/6/25 12:00:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care
    Get the next $CHE alert in real time by email

    Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 3:40 PM (PDT) at the Encore at the Wynn Las Vegas.

    The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days.

    Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services.

    Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250506469213/en/

    Michael D. Witzeman

    (513) 762-6714

    Get the next $CHE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHE

    DatePrice TargetRatingAnalyst
    3/4/2022$609.00 → $579.00Outperform
    RBC Capital
    7/29/2021$604.00 → $609.00Outperform
    RBC Capital
    More analyst ratings

    $CHE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025

      Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 3:40 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS i

      5/6/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Reports First-Quarter 2025 Results

      Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2025, versus the comparable prior-year period. Results for Quarter Ended March 31, 2025 Consolidated operating results: Revenue increased 9.8% to $646.9 million GAAP Diluted Earnings-per-Share (EPS) of $4.86, an increase of 14.6% Adjusted Diluted EPS of $5.63, an increase of 8.3% VITAS segment operating results: Net Patient Revenue of $407.4 million, an in

      4/23/25 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24

      Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 24, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/ey8mpmti. Participants may also register via teleconference at: https:/

      4/1/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Financials

    Live finance-specific insights

    See more
    • Chemed Reports First-Quarter 2025 Results

      Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2025, versus the comparable prior-year period. Results for Quarter Ended March 31, 2025 Consolidated operating results: Revenue increased 9.8% to $646.9 million GAAP Diluted Earnings-per-Share (EPS) of $4.86, an increase of 14.6% Adjusted Diluted EPS of $5.63, an increase of 8.3% VITAS segment operating results: Net Patient Revenue of $407.4 million, an in

      4/23/25 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24

      Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 24, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/ey8mpmti. Participants may also register via teleconference at: https:/

      4/1/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Reports Fourth-Quarter 2024 Results

      Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, to provide additional context and perspective to reported operational results. Chemed's previously reported non-GAAP metrics during the four sequential qu

      2/26/25 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RBC Capital reiterated coverage on Chemed with a new price target

      RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $579.00 from $609.00 previously

      3/4/22 8:31:07 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • RBC Capital reiterated coverage on Chemed with a new price target

      RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $609.00 from $604.00 previously

      7/29/21 10:52:58 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Oppenheimer reiterated coverage on Chemed with a new price target

      Oppenheimer reiterated coverage of Chemed with a rating of Outperform and set a new price target of $580.00 from $600.00 previously

      3/3/21 8:11:56 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/13/24 5:01:01 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/9/23 11:12:43 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/9/22 3:33:36 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Executive vice president Lee Spencer S sold $866,790 worth of Capital Stock (1,500 units at $577.86), decreasing direct ownership by 9% to 16,127 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/8/25 9:13:22 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • President and CEO Mcnamara Kevin J sold $864,675 worth of Capital Stock (1,500 units at $576.45), exercised 10,000 units of Capital Stock at a strike of $471.74 and covered exercise/tax liability with 8,982 units of Capital Stock, decreasing direct ownership by 0.47% to 101,197 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/6/25 11:59:31 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • President and CEO Mcnamara Kevin J sold $615,330 worth of Capital Stock (1,000 units at $615.33), decreasing direct ownership by 0.97% to 101,679 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      4/1/25 11:05:10 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    SEC Filings

    See more
    • SEC Form 10-Q filed by Chemed Corp

      10-Q - CHEMED CORP (0000019584) (Filer)

      4/28/25 9:06:58 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - CHEMED CORP (0000019584) (Filer)

      4/23/25 4:30:27 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form DEF 14A filed by Chemed Corp

      DEF 14A - CHEMED CORP (0000019584) (Filer)

      4/7/25 9:32:08 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Leadership Updates

    Live Leadership Updates

    See more
    • VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

      VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama. The transaction is structured as an asset purchase and parties will seek to close the tra

      3/13/24 9:00:00 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO

      Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's Vice President and Controller and serves as Chemed's principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates t

      12/18/23 1:20:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Announces the Retirement of David P. Williams

      Chemed Corporation (NYSE:CHE) – After more than three decades, Executive Vice President and Chief Financial Officer David P. Williams has announced that he will retire as Chemed's Chief Financial Officer as of December 31, 2023, but Mr. Williams will continue to work with Chemed for the transition period and beyond in providing his guidance and the benefit of his expertise to the executive team and the Board of Directors. Throughout his career, David helped lead Chemed and its subsidiaries through unprecedented economic growth. "It has been a privilege to work with David as an integral part of our management team for these last three decades," said Chemed Chief Executive Officer, Kevin

      11/3/23 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • VP and Chief Legal Officer Judkins Brian C bought $75,328 worth of Capital Stock (145 units at $519.50), increasing direct ownership by 9% to 1,678 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      12/30/24 11:10:35 AM ET
      $CHE
      Medical/Nursing Services
      Health Care